ROCHESTER, Minn. — Mayo Clinic’s Business Development team, a leader in healthcare commercialization, is expanding its reach with a bold new initiative: the Mayo Venture Partner (MVP) program. The program brings together top industry experts to develop breakthrough technologies, invest in promising startups, and launch new healthcare ventures.
As the healthcare landscape evolves, Mayo Clinic is tapping into the expertise of seasoned entrepreneurs and executives. These MVPs will collaborate closely with Mayo’s world-class researchers and clinicians to identify high-impact opportunities, form new companies, and fast-track innovations that improve patient care.
Meet the Inaugural Mayo Venture Partners:
Amy DuRoss – A healthcare innovation leader with experience in diagnostics, policy, and commercialization.
Audrey Greenberg – A biotech entrepreneur known for scaling life sciences ventures.
Brian Poger – A digital health strategist with a strong track record in healthcare services.
Together with Mayo Clinic’s Business Development team, the MVPs will drive strategic partnerships and real-world healthcare advancements.
Mayo Clinic’s Commercialization Impact:
- Generated $1.2 billion in revenue to support research, education, and clinical care.
- Helped launch 180+ companies.
- Licensed 4,848 technologies through 2,913 agreements.
- Secured 4,159 patents.
A Vision for the Future of Healthcare:
The MVP program aligns with Mayo Clinic’s mission to:
Speed up innovation – Turning research into real-world solutions.
Improve patient care – Delivering new treatments and lowering costs.
Strengthen partnerships – Combining Mayo’s expertise with industry leaders for greater impact.
This initiative offers a unique opportunity for investors, CEOs, and innovators to collaborate with Mayo Clinic in shaping a patient-centered healthcare future.
More About the MVPs:
Amy DuRoss
Amy specializes in launching companies at the intersection of biopharma, software, and life sciences. Former CEO of Vineti, she also held leadership roles at GE Ventures and helped create California’s $8.5 billion stem cell initiative. She holds an MBA and MA/BA from Stanford.
Audrey Greenberg
Audrey co-founded the Center for Breakthrough Medicines (CBM), a leader in cell and gene therapy manufacturing, which was later acquired. She has managed $90 billion in assets as a private equity executive and holds an MBA from Wharton.
Brian Poger
Brian has founded multiple healthcare startups, including Benefitter and Senior Educators. He has held leadership roles at Aon, UnitedHealthcare, and Eli Lilly and holds an MBA from Kellogg.
This program reinforces Mayo Clinic’s commitment to transforming healthcare through innovation, collaboration, and cutting-edge technology.
Related topics:
